Evidence map›Paper›PMID 34213605›Full record

ArticleEuropean journal of nutrition2022

Factors associated with serum ferritin levels and iron excess: results from the EPIC-EurGast study.

Lucía Iglesias-Vázquez, Victoria Arija, Núria Aranda, Elom K Aglago, Amanda J Cross, Matthias B Schulze, Daniel Quintana Pacheco, Tilman Kühn, Elisabete Weiderpass, Rosario Tumino and 14 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Genetic history of Scythia.Science advances · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 14 institutions in 6 countries.

Lucía Iglesias-VázquezResearch group of Nutrition and Mental Health (NUTRISAM), Unit of Nutrition and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili (URV), Tarragona, Spain.ORCID http://orcid.org/0000-0001-7131-4144
Victoria ArijaResearch group of Nutrition and Mental Health (NUTRISAM), Unit of Nutrition and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili (URV), Tarragona, Spain. victoria.arija@urv.cat.ORCID http://orcid.org/0000-0002-1758-0975
Núria ArandaResearch group of Nutrition and Mental Health (NUTRISAM), Unit of Nutrition and Public Health, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili (URV), Tarragona, Spain.ORCID http://orcid.org/0000-0001-9708-747X
Elom K AglagoInternational Agency for Research on Cancer (IARC), Lyon, France.ORCID http://orcid.org/0000-0002-0442-3284
Amanda J CrossDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-0893-2377
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.ORCID http://orcid.org/0000-0002-0830-5277
Daniel Quintana PachecoDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Tilman KühnDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0001-7702-317X
Elisabete WeiderpassInternational Agency for Research on Cancer (IARC), Lyon, France.ORCID http://orcid.org/0000-0003-2237-0128
Rosario TuminoCancer Registry and Histopathology Department, Provincial Health Authority (ASP 7) Ragusa, Ragusa, Italy.ORCID http://orcid.org/0000-0003-2666-414X
Daniel Redondo-SánchezEscuela Andaluza de Salud Pública (EASP), Granada, Spain.ORCID http://orcid.org/0000-0001-9986-915X
Maria Santucci de MagistrisAzienda Ospedialiera Universitaria (A.O.U.) Federico II, Naples, Italy.
Domenico PalliCancer Risk Factors and Life-Style Epidemiology Unit Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Villa delle Rose, Florence, Italy.ORCID http://orcid.org/0000-0002-5558-2437
Eva ArdanazNavarra Public Health Institute, Pamplona, Spain.ORCID http://orcid.org/0000-0001-8434-2013
Nasser LaoualiParis-Saclay University, UVSQ, University Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" Team, CESP, 94805, Villejuif, France.ORCID http://orcid.org/0000-0002-8532-456X
Emily SonestedtNutritional Epidemiology, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.ORCID http://orcid.org/0000-0002-0747-4562
Isabel DrakeNutritional Epidemiology, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.ORCID http://orcid.org/0000-0002-6500-6310
Lucía RizzoloUnit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, Nutrition and Cancer Group, Bellvitge Biomedical Research Institute -(IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Carmen SantiusteCIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Carlotta SacerdoteUnit of Cancer Epidemiology, Città Della Salute e Della Scienza University-Hospital, Via Santena 7, 10126, Turin, Italy.ORCID http://orcid.org/0000-0002-8008-5096
Ramón QuirósEPIC Asturias, Public Health Directorate, Asturias, Spain.
Pilar AmianoCIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.ORCID http://orcid.org/0000-0003-3986-7026
Antonio AgudoUnit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, Nutrition and Cancer Group, Bellvitge Biomedical Research Institute -(IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.ORCID http://orcid.org/0000-0001-9900-5677
Paula JakszynUnit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, Nutrition and Cancer Group, Bellvitge Biomedical Research Institute -(IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. paujak@iconcologia.net.ORCID http://orcid.org/0000-0003-0672-8847
Institut de Recerca Biomèdica Catalunya Sud · ESInstitut d'Investigació Biomédica de Bellvitge · ESCentre international de recherche sur le cancer · FRGerman Cancer Research Center · DELund University · SEBiogipuzkoa Health Research Institute · ESGobierno del Principado de Asturias · ESImperial College London · GBInserm · FRInstituto de Investigación Biosanitaria de Granada · ESInstituto de Salud Pública de Navarra · ESInstituto Murciano de Investigación Biosanitaria · ESPiedmont Reference Center for Epidemiology and Cancer Prevention · ITUniversity of Potsdam · DE

Funding

Cancer Research UK 25004Medical Research Council MR/M012190/1World Health Organization 001
6 · The paper itself

Abstract

purposeExcess iron is involved in the development of non-communicable diseases such as cancer, type 2 diabetes and cardiovascular conditions. We aimed to describe the prevalence of excess iron and its determinants in healthy European adults.

methodsSociodemographic, lifestyle, iron status, dietary information, and HFE genotyping were obtained from controls from the nested case-control study EPIC-EurGast study. High sensitivity C-reactive protein (hsCRP) was measured to address possible systemic inflammation. Descriptive and multivariate analyses were used to assess iron status and its determinants.

resultsOut of the 828 participants (median age: 58.7 years), 43% were females. Median serum ferritin and prevalence of excess iron were 143.7 µg/L and 35.2% in males, respectively, and 77 µg/L and 20% in females, both increasing with latitude across Europe. Prevalence of HFE C282Y mutation was significantly higher in Northern and Central Europe (~ 11%) than in the South (5%). Overweight/obesity, age, and daily alcohol and heme iron intake were independent determinants for iron status, with sex differences even after excluding participants with hsCRP > 5 mg/L. Obese males showed a greater consumption of alcohol, total and red meat, and heme iron, compared with those normal weight.

conclusionObesity, higher alcohol and heme iron consumption were the main risk factors for excess iron in males while only age was associated with iron overload in females. Weight control and promoting healthy lifestyle may help prevent iron overload, especially in obese people. Further research is needed to clarify determinants of excess iron in the healthy adult population, helping to reduce the associated comorbidities.

Indexed as

Diabetes Mellitus, Type 2HemochromatosisIron OverloadCase-Control StudiesFemaleFerritinsHemochromatosis ProteinHistocompatibility Antigens Class IHumansIronMaleMiddle AgedFerritinsHemochromatosis ProteinHistocompatibility Antigens Class IIronEPICExcess ironIron overloadIron statusSerum ferritin

Identifiers

PMID34213605
OpenAlexW3176393517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.